Pharmaron Holding
A premier R&D service provider supporting the life science industry.
Launch date
Employees
Market cap
-
Enterprise valuation
$160—240m (Dealroom.co estimates Feb 2011.)
Beijing China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | Series A | |
$40.0m | Series C | ||
$280m | Growth Equity VC | ||
| N/A | N/A | IPO | |
* | N/A | $589m | Post IPO Equity |
| Total Funding | $320m | ||
Related Content
Recent News about Pharmaron Holding
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
ACQUISITION by Pharmaron Holding Jan 2017
ACQUISITION by Pharmaron Holding Nov 2020
ACQUISITION by Merck Nov 2022
exited
ACQUISITION by Pharmaron Holding Feb 2021
